These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25539674)

  • 1. Early effect of screening programmes on incidence and mortality rates of colorectal cancer.
    Zorzi M; Fedeli U
    Gut; 2015 Jun; 64(6):1007. PubMed ID: 25539674
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
    Logan RF; Halloran SP
    Gut; 2015 Jun; 64(6):1006-7. PubMed ID: 25512640
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
    Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
    Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening: what program is most effective?
    Lieberman D
    Gastrointest Endosc; 2015 Mar; 81(3):710-2. PubMed ID: 25708758
    [No Abstract]   [Full Text] [Related]  

  • 5. Flexible sigmoidoscopy screening reduces colorectal cancer incidence and deaths, study shows.
    Mayor S
    BMJ; 2014 Aug; 349():g5119. PubMed ID: 25124876
    [No Abstract]   [Full Text] [Related]  

  • 6. Population and individual benefits of colorectal cancer screening.
    Campbell C
    Gut; 2010 Aug; 59(8):1016-7. PubMed ID: 20639246
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.
    Whynes DK; Mangham CM; Balfour TW; Scholefield JH
    Gut; 2010 Aug; 59(8):1088-93. PubMed ID: 20639252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New fecal occult blood tests may improve adherence and mortality rates.
    Kumaravel V; Hayden SP; Hall GS; Burke CA
    Cleve Clin J Med; 2011 Aug; 78(8):515-20. PubMed ID: 21807923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bowel cancer screening.
    Robertson L; Roberts G; Cooney T; Holdaway R; Krijger P; Crengle S; Derrett S
    N Z Med J; 2017 Sep; 130(1461):84-85. PubMed ID: 28859073
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology and screening: what's new?
    Bonelli L
    Colorectal Dis; 2015 Jan; 17 Suppl 1():10-4. PubMed ID: 25511855
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal cancer screening: a global overview of existing programmes.
    Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
    Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Screening.
    Moore JS; Aulet TH
    Surg Clin North Am; 2017 Jun; 97(3):487-502. PubMed ID: 28501242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Necessity and feasibility of screening for colorectal cancer in China].
    Zhang SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Blood Testing or Colonoscopy: What Is the Best Method for Colorectal Cancer Screening?
    Redberg RF
    JAMA Intern Med; 2016 Aug; 176(8):1071-3. PubMed ID: 27303931
    [No Abstract]   [Full Text] [Related]  

  • 15. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.
    Zorzi M; Fedato C; Grazzini G; Stocco FC; Banovich F; Bortoli A; Cazzola L; Montaguti A; Moretto T; Zappa M; Vettorazzi M
    Gut; 2011 Jul; 60(7):944-9. PubMed ID: 21193461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.
    Oliphant R; McLoone P; Morrison D
    Gut; 2011 Aug; 60(8):1163-4. PubMed ID: 21193450
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer.
    Hamza S; Cottet V; Touillon N; Dancourt V; Bonithon-Kopp C; Lepage C; Faivre J
    Dig Liver Dis; 2014 Dec; 46(12):1121-5. PubMed ID: 25241134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subjective decision of cessation of colorectal cancer screening.
    Daniel CL; Keyes D; Gilreath K
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):698-699. PubMed ID: 28895544
    [No Abstract]   [Full Text] [Related]  

  • 19. Colorectal Cancer Screening.
    Garborg K
    Surg Clin North Am; 2015 Oct; 95(5):979-89. PubMed ID: 26315518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening].
    García Sánchez J
    Rev Clin Esp; 2012 Jul; 212(7):407. PubMed ID: 22937539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.